After signing up, you'll start to receive regular news updates from us.
GE Healthcare to Host Scientific Meeting
Complete the form below to unlock access to ALL audio articles.
Attended by leading scientists from both academia and industry, the conference will address many key challenges facing the industry, such as how label-free binding studies can advance fragment based drug discovery and how label-free detection can provide the insights needed to drive progress in biotherapeutic development.
The conference is comprised of educational and scientific sessions, including key lectures, workshops, and round-table sessions covering the latest advances and new solutions. The scientific sessions highlight three forefront topics:
• Fragment and small molecule screening and characterization
Keynote speaker: Tony Giannetti, Genentech, USA.
The short history of fragment based lead discovery and the impact of the quantitative optical biosensor.
• Biotherapeutic and vaccine discovery and development
Keynote Speaker: Indresh Srivastava, NIH, USA.
Biophysical characterization of vaccines
• Structure-activity relationship
Keynote speaker: David Wilson, Georgia State University, USA.
Biosensor-SPR and ITC applications to nucleic acid Interactions: New approaches and biological applications
Delegates will also have the opportunity to take part in pre-conference tutorials addressing the use of Biacore™, MicroCal™ ITC and MicroCal DSC systems, as well as workshops providing educational and practical information on a range of application and methodology-related topics.
